Fig. 1
From: Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
mRNA expression levels of PCSK9 in different tumor types. (A) Expression level of PCSK9 in unpaired samples among 33 tumor types. (B) The expression level of PCSK9 in paired samples in BLCA, BRCA, COAD, ESCA, HNSC, LIHC, READ, STAD, THCA, and UCEC. (C) Expression level of PCSK9 in paired samples in KIRC, KIRP, LUAD, and PRAD. ns P ≥ 0.05; *P < 0.05; **P < 0.01; ***P < 0.001